Literature DB >> 29099489

Deconstructing networks of p53-mediated tumor suppression in vivo.

Alyssa M Kaiser1, Laura D Attardi1,2.   

Abstract

The transcription factor p53 is a vital tumor suppressor. Upon activation by diverse stresses including oncogene activation, DNA damage, hypoxia and nutrient deprivation, p53 activates a panoply of target genes and orchestrates numerous downstream responses that suppress tumorigenesis. Although early studies of p53 suggested that its ability to induce cell cycle arrest, senescence and apoptosis programs accounted for its tumor-suppressor activity, more recent studies have challenged this notion. Moreover, p53 regulates a suite of additional processes, such as metabolism, stem cell function, invasion and metastasis. The processes p53 coordinately regulates to enact tumor suppression, and how such regulation occurs, thus remain elusive. In this review, we will summarize our current knowledge of p53-mediated tumor-suppressive mechanisms gleaned from in vivo studies in mouse models.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29099489      PMCID: PMC5729531          DOI: 10.1038/cdd.2017.171

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  120 in total

1.  Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.

Authors:  S W Lowe; T Jacks; D E Housman; H E Ruley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

Review 2.  Reactive oxygen species in cancer.

Authors:  Geou-Yarh Liou; Peter Storz
Journal:  Free Radic Res       Date:  2010-05

3.  The differential effects of mutant p53 alleles on advanced murine lung cancer.

Authors:  Erica L Jackson; Kenneth P Olive; David A Tuveson; Roderick Bronson; Denise Crowley; Michael Brown; Tyler Jacks
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

4.  Suppression of induced pluripotent stem cell generation by the p53-p21 pathway.

Authors:  Hyenjong Hong; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Osami Kanagawa; Masato Nakagawa; Keisuke Okita; Shinya Yamanaka
Journal:  Nature       Date:  2009-08-09       Impact factor: 49.962

5.  Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas.

Authors:  Keisuke Kurose; Kristie Gilley; Satoshi Matsumoto; Peter H Watson; Xiao-Ping Zhou; Charis Eng
Journal:  Nat Genet       Date:  2002-10-15       Impact factor: 38.330

6.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

7.  Ferroptosis as a p53-mediated activity during tumour suppression.

Authors:  Le Jiang; Ning Kon; Tongyuan Li; Shang-Jui Wang; Tao Su; Hanina Hibshoosh; Richard Baer; Wei Gu
Journal:  Nature       Date:  2015-03-18       Impact factor: 49.962

8.  Evidence for nonautonomous effect of p53 tumor suppressor in carcinogenesis.

Authors:  Hippokratis Kiaris; Ioulia Chatzistamou; George Trimis; Matrisa Frangou-Plemmenou; Agatha Pafiti-Kondi; Anastasios Kalofoutis
Journal:  Cancer Res       Date:  2005-03-01       Impact factor: 12.701

9.  Uncoupling cancer mutations reveals critical timing of p53 loss in sarcomagenesis.

Authors:  Nathan P Young; Denise Crowley; Tyler Jacks
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

10.  Direct cell reprogramming is a stochastic process amenable to acceleration.

Authors:  Jacob Hanna; Krishanu Saha; Bernardo Pando; Jeroen van Zon; Christopher J Lengner; Menno P Creyghton; Alexander van Oudenaarden; Rudolf Jaenisch
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

View more
  84 in total

1.  A potential link between p53, cell competition and ribosomopathy in mammals and in Drosophila.

Authors:  Nicholas E Baker; Marianthi Kiparaki; Chaitali Khan
Journal:  Dev Biol       Date:  2018-12-02       Impact factor: 3.582

2.  The Spatiotemporal Pattern and Intensity of p53 Activation Dictates Phenotypic Diversity in p53-Driven Developmental Syndromes.

Authors:  Margot E Bowen; Jacob McClendon; Hannah K Long; Aryo Sorayya; Jeanine L Van Nostrand; Joanna Wysocka; Laura D Attardi
Journal:  Dev Cell       Date:  2019-06-06       Impact factor: 12.270

Review 3.  Skin immunity and its dysregulation in psoriasis.

Authors:  Caterina Lanna; Mara Mancini; Roberta Gaziano; Maria Vittoria Cannizzaro; Marco Galluzzo; Marina Talamonti; Valentina Rovella; Margherita Annicchiarico-Petruzzelli; Gerry Melino; Ying Wang; Yufang Shi; Elena Campione; Luca Bianchi
Journal:  Cell Cycle       Date:  2019-08-15       Impact factor: 4.534

4.  Multi-omics profiling of calcium-induced human keratinocytes differentiation reveals modulation of unfolded protein response signaling pathways.

Authors:  Anna Michaletti; Mara Mancini; Artem Smirnov; Eleonora Candi; Gerry Melino; Lello Zolla
Journal:  Cell Cycle       Date:  2019-07-22       Impact factor: 4.534

Review 5.  Context is everything: extrinsic signalling and gain-of-function p53 mutants.

Authors:  Ivano Amelio; Gerry Melino
Journal:  Cell Death Discov       Date:  2020-03-23

Review 6.  The role of noncoding RNAs in epithelial cancer.

Authors:  Massimiliano Agostini; Carlo Ganini; Eleonora Candi; Gerry Melino
Journal:  Cell Death Discov       Date:  2020-03-12

Review 7.  The role of MDM2-p53 axis dysfunction in the hepatocellular carcinoma transformation.

Authors:  Hui Cao; Xiaosong Chen; Zhijun Wang; Lei Wang; Qiang Xia; Wei Zhang
Journal:  Cell Death Discov       Date:  2020-06-19

Review 8.  Ceramide Signaling and p53 Pathways.

Authors:  Kristen A Jeffries; Natalia I Krupenko
Journal:  Adv Cancer Res       Date:  2018-06-01       Impact factor: 6.242

9.  ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes.

Authors:  Matteo Cassandri; Alessio Butera; Ivano Amelio; Anna Maria Lena; Manuela Montanaro; Alessandro Mauriello; Lucia Anemona; Eleonora Candi; Richard A Knight; Massimiliano Agostini; Gerry Melino
Journal:  Oncogene       Date:  2020-04-20       Impact factor: 9.867

10.  P73 C-terminus is dispensable for multiciliogenesis.

Authors:  Niall Buckley; Emanuele Panatta; Nobuhiro Morone; Masafumi Noguchi; Luca Scorrano; Richard A Knight; Ivano Amelio; Gerry Melino
Journal:  Cell Cycle       Date:  2020-06-25       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.